AML 18 – Clinical Trial Open to Recruitment
13 Aug. 2016Research FOR Patients
-For an informed and empowered opinion-
All the trials listed on our site have been properly vetted for scientific accuracy. Many thanks to Dr Simone Green – Hull and East Yorkshire Hospitals NHS Trust - for the continuous work in updating the listing.
AML 18
-
- SUB-TYPE OF MDS: MDS with 10% or more bone marrow blasts; also acute myeloid leukaemia
- SEVERITY OF MDS: Intermediate – 2 or High Risk
- NAME OF DRUG: Mylotarg, AC220 (a novel drug that blocks the action of a gene – FLT3, which is important in the growth of blood cells
- Aims and benefits: This trial is designed for patients over 60 years considered fit for intensive chemotherapy. It aims to answer several therapeutic questions.
- To determine if a new dosing schedule of Mylotarg (two doses) is better than the current standard of a single dose.
Does adding AC220 improve outcomes. - Is monitoring minimal residual disease (MRD) after completing course 1 of chemotherapy (by regular bone marrow biopsies) of clinical value.
- To compare the effectiveness of two different chemotherapy regimens (Daunorubicin + high dose Cytarabine vs Intermediate dose Cytarabine) when used as course 3 of chemotherapy.
- To assess the value of a reduced intensity allogeneic stem cell transplant in maintaining remission.
- To determine if a new dosing schedule of Mylotarg (two doses) is better than the current standard of a single dose.
- Basic inclusion criteria:
- Acute myeloid leukaemia (excluding acute promyelocytic leukaemia) or high risk Myelodysplastic Syndrome (>10% bone marrow blasts)
- Over the age of 60, but patients under this age are eligible if they are not considered eligible for the AML 19 trial
- Suitable for intensive chemotherapy
- Adequate kidney function
- Basic exclusion criteria:
- Patients who previously received demethylation treatment (eg. Azacitidine) for high risk MDS (>10% blasts)
Previous chemotherapy for acute myeloid leukaemia - Concurrent active malignancy excluding basal cell carcinoma
- Pregnant or lactating
- Known infection with human immunodeficiency virus (HIV)
- Patients who previously received demethylation treatment (eg. Azacitidine) for high risk MDS (>10% blasts)
- Trial sites/locations and name of physician in charge of trial:
- Aberdeen Royal Infirmary
- Blackpool Victoria Hospital
- Derriford Hospital (Plymouth Hospital)
- Ninewells Hospital
- Poole General Hospital
- Queen Alexandra Hospital (Portsmouth)
- St Helier Hospital
- University College London Hospital
- University Hospital of Wales
- NHS Lanarkshire (Monklands, Wishaw and Hairmyres Hospital)
- Christie Hospital
- Stafford Hospital
- Nottingham
- Royal Free Hospital
- Raigmore Hospital
- Russells Hall Hospital
- New Victoria Hospital
- Victoria Hospital (Kirkcaldy)
- Birmingham Heartland Hospital
- Salisbury District Hospital
- Kettering General Hospital
- Bristol Haematology & Oncology Centre
- Crosshouse Hospital (Ayrshire and Arran Health Board)
- Ayr Hospital (Ayrshire and Arran Health Board)
- Basingstoke and North Hampshire Hospital
- Beatson General Hospital (Gartnavel General Hospital)
- Manchester Royal Infirmary
- Hillingdon Hospital
- Torbay District General Hospital
- Lincoln County Hospital
- Salford Royal Hospital
- Western General Hospital
- Royal Bournemouth General Hospital
- Royal Cornwall Hospital (Treliske)
- Aintree University Hospital
- Ysbyty Gwynedd Hospital
- Queen's Hospital, Romford
- Ysbyty Glan Clwyd
- Arrowe Park Hospital (Wirral)
- Royal Liverpool University Hospital
- Musgrove Park Hospital (Taunton & Somerset Hospital)
- Southampton General Hospital
- Rigshospitalet University Hospital
- Roskilde Hospital
- Countess Of Chester Hospital
- Aalborg Hospital
- Herlev University Hospital
- Leeds Teaching Hospital NHS Trust (St James)
- University Hospital Odense
- Royal Stoke University Hospital
- Castle Hill Hospital
- University Hospitals Coventry and Warwickshire (UHCW, Coventry)
- Cheltenham General Hospital
- Royal Devon & Exeter Hospital
- Worcestershire Acute Hospitals NHS Trust
- Queen Elizabeth Hospital Birmingham
- Great Western Hospital
- Leicester Royal Infirmary
- Aarhus University Hospital
- Churchill Hospital
- Freeman Hospital
- Whiston Hospital & St Helens
- Addenbrooke's Hospital
- St Bartholomew's Hospital
- Royal Marsden
- Bradford Royal Infirmary
- Guy's Hospital
- James Cook University Hospital
- Milton Keynes University Hospital
- Singleton Hospital
- More information:
Please read information and always discuss trial information with your own physician.